Patents by Inventor Serge Haan

Serge Haan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers for cancer diagnosis, prediction or staging
    Patent number: 11834717
    Abstract: The present invention relates to a method for predicting clinical outcome for a subject diagnosed with colorectal cancer, skin cancer, head and neck cancer or lung cancer. It also relates to a method for predicting whether a subject has a predisposition to develop such cancers as well as to a method for aiding the staging of such cancers in a subject. The methods of the present invention apply to the biomarkers MYO5B and/or RAB8A and optionally in addition to RAB9A, RAB10, RAB11A, RAB25, CDC42, RAC and/or RhoA.
    Type: Grant
    Filed: August 10, 2018
    Date of Patent: December 5, 2023
    Assignee: Universite du Luxembourg
    Inventors: Elisabeth Letellier, Martine Schmitz, Aurelien Ginolhac, Serge Haan
  • NOVEL BIOMARKERS FOR CANCER DIAGNOSIS, PREDICTION OR STAGING
    Publication number: 20200362417
    Abstract: The present invention relates to a method for predicting clinical outcome for a subject diagnosed with colorectal cancer, skin cancer, head and neck cancer or lung cancer. It also relates to a method for predicting whether a subject has a predisposition to develop such cancers as well as to a method for aiding the staging of such cancers in a subject. The methods of the present invention apply to the biomarkers MYO5B and/or RAB8A and optionally in addition to RAB9A, RAB10, RAB11A, RAB25, CDC42, RAC and/or RhoA.
    Type: Application
    Filed: August 10, 2018
    Publication date: November 19, 2020
    Inventors: Elisabeth Letellier, Martine Schmitz, Aurelien Ginholac, Serge Haan